CERVICAL CANCER: EARLY DETECTION AND EDUCATIONAL ACTIONS WITH UNIVERSITY STUDENTS

Authors

  • Rodrigo Covre Vieira Universidade Federal do Pará (UFPA), Belém, Pará, Brasil.
  • Jaqueline de Sá Lima Heninng Universidade Federal do Pará (UFPA), Belém, Pará, Brasil.
  • Camila Carla da Silva Costa Universidade Federal do Pará (UFPA), Belém, Pará, Brasil
  • Benedito Antônio Pinheiro dos Prazeres Universidade Federal do Pará (UFPA), Belém, Pará, Brasil
  • Josinaide Quaresma Trindade Universidade Federal do Pará (UFPA), Belém, Pará, Brasil
  • Rafaella do Nascimento Ferreira Universidade Federal do Pará (UFPA), Belém, Pará, Brasil
  • Edna Aoba Yassui Ishikawa Laboratório de Biologia Molecular e Celular do Núcleo de Medicina Tropical (NMT), Belém, Pará, Brasil
  • Mihoko Yamamoto Tsutsumi Universidade Federal do Pará (UFPA), Belém, Pará, Brasil
  • Maisa Silva de Sousa Laboratório de Biologia Molecular e Celular do Núcleo de Medicina Tropical (NMT), Belém, Pará, Brasil

DOI:

https://doi.org/10.23901/1679-4605.2017v13n1p72-82

Keywords:

Cervical cancer. Pap test. Human papillomavirus. University extension

Abstract

Background: Cervical cancer (CC) is the most common cancer among women from northern Brazil. The periodic performance of Pap testing enables the identification of precursor lesions of cancer and provides high rates of recovery. Objectives: To promote educational measures and early detection of CC among university students, using the Pap test, the polymerase chain reaction (PCR) test for human papillomavirus (HPV), and advice about the risk factors associated with viral infections. Methods: This study is part of a university extension program focused on health care for adolescents and young public university students in the city of Belem do Pará, in northern Brazil. We conducted a descriptive study in the years 2013 and 2014 that involved 329 students. The students completed a socio-epidemiological questionnaire and provided cervico-vaginal material for cytological and PCR analysis. Results: The profile of the female participants of the study was as follows: aged 25 years or less (n = 202; 61.3%); non-smokers (n = 327; 99%); single (n = 298; 90%); multiple sexual partners (n = 199; 60.4%). Cytological abnormalities were observed in 12.8% (n = 42) of the samples and HPV infection was found in 25.8% (n = 85). Abnormal cytology results, where the presence of viral DNA was confirmed by PCR, were more frequent in younger women. Statistically significant associations were demonstrated between HPV infection and the occurrence of low grade and high grade squamous intraepithelial lesions (LSIL/HSIL), the age at menarche, and parity. Conclusion: The extension activity provided wide coverage of the target population. The high percentages of cytological abnormalities and HPV infections observed in the study reinforce the importance of university extension in helping to prevent sexually transmitted infections and CC in the study region.

 

References

AYRES, M. et al. BioEstat 5.3. 2011. Disponível em: <http://www.mamiraua.org.br/pt-br/downloads/programas/>. Acesso em: 13 abr. 2014.

BRASIL. Ministério da Agricultura, Pecuária e Abastecimento. Empresa Brasileira de Pesquisa Agropecuária (EMBRAPA). Fundamentos teórico-práticos e protocolos de extração e de amplificação de DNA por meio da técnica de Reação em Cadeia da Polimerase. São Carlos, 2007. Disponível em: <http://www.alice.cnptia.embrapa.br/bitstream/doc/48295/1/LivroProtMolecular.pdf>. Acesso em: 24 nov. 2014.

BROWN, D. R. et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. The Journal of Infectious Diseases, Chicago, v. 199, n. 7, p. 926-935, abr. 2009.

BRUNI, L. et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. The Journal of Infectious Diseases, Chicago, v. 202, n. 12, p. 1789-99, dez. 2010.

CASTLE, P. E. et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ, London, v. 28, n. 339, jul. 2009.

DE SANJOSÉ, S. ET AL. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infectious Diseases, New York, v. 7, n. 7, p. 453-459, jul. 2007.

DEMIR, E. T. et al. The prevalence of different HPV types in Turkish women with a normal Pap smear. Journal of Medical Virology, New York, v. 84, n. 8, p. 1242-1247, ago. 2012.

DUNNE, E. F. et al. Prevalence of HPV infection among females in the United States. JAMA, Chicago, v. 297, n. 8, p. 813-819, fev. 2007.

FERRERA, A. et al. Assessment of HPV infection among female university students in Honduras via Roche linear array. International Journal of Gynaecology and Obstetrics, New York, v. 113, n. 2, p. 96-99, maio 2011.

HO, C. M. et al. Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia. International Journal of Cancer, New York, v. 127, n. 3, p. 622-632, ago. 2010.

HOWELL-JONES, R. et al. Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation. Vaccine, Kidlinton, v. 6, n. 30, p. 3867-3875, jun. 2012.

INSTITUTO NACIONAL DE CÂNCER (INCA). Programa Nacional de Controle do Câncer do Colo do Útero. Rio de Janeiro, 2010. Disponível em: <http://www2.inca.gov.br/wps/wcm/connect/acoes_programas/site/home/nobrasil/programa_nacional_controle_cancer_colo_utero/deteccao_precoce#SISCOLO>. Acesso em: 5 jun. 2015.

INSTITUTO NACIONAL DE CÂNCER (INCA). Coordenação Geral de Ações Estratégicas. Divisão de Apoio à Rede de Atenção Oncológica. Diretrizes brasileiras para o rastreamento do câncer do colo do útero. Rio de Janeiro, 2012.

INSTITUTO NACIONAL DE CÂNCER (INCA). Estimativa 2014. Incidência do Câncer no Brasil. Rio de Janeiro, 2014. Disponível em: <http://www.inca.gov.br/estimativa/2014/>. Acesso em: 13 maio 2015.

INTERNATIONAL AGENCY OF RESEARCH ON CANCER (IARC). Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. Lyon: WHO: IARC, 2007. 636 p. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, v. 90).

INTERNATIONAL AGENCY FOR RESEARCH OF CANCER (IARC). GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence in world in 2012. Lyon: IARC, 2012. Disponível em: <http://globocan.iarc.fr/Default.aspx>. Acesso em: 23 set. 2015.

KAVANAGH, K. et al. Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact. BMC Infectious Diseases, London, v. 13, n. 519, nov. 2013.

MANOS, M. M. et al. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, New York, v. 7, p. 209-214, 1989.

NAKAGAWA, J. T. et al. Fatores associados ao câncer invasivo do colo do útero no estado de Mato Grosso. Ciência, Cuidado e Saúde, Maringá, v. 9, n. 4, p. 799-805, 2010.

OAKESHOTT, P. et al. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ, London, v. 344, n. 4168, jun. 2012.

ORGANIZAÇÃO MUNDIAL DE SAÚDE (OMS). WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in world. Summary Report 2010. Disponível em: . Acesso em: 12 jun 2015.

PANATTO, D. et al. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? BMC Infectious Diseases, London, v. 13, n. 575, dez. 2013.

RABELO-SANTOS, S. H. et al. DNA recovery from Hybrid Capture II samples stored in specimen transport medium with denaturing reagent, for the detection of human papillomavirus by PCR. Journal of Virological Methods, Amsterdam, v. 126, n. 1/2, p. 197-201, jun. 2005.

WALBOOMERS, J. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology, Chichester, v. 189, n. 1, p. 12-19, set. 1999.

Published

2017-03-31

Issue

Section

Artigos